Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving them by intraperitoneal
infusion may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of intraperitoneal combination
chemotherapy in treating patients who have stage III ovarian epithelial cancer or
gastrointestinal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health